Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures

被引:123
作者
Gijbels, Domien [1 ,3 ]
Alders, Geert [3 ]
Van Hoof, Elke [2 ]
Charlier, Caroline [3 ]
Roelants, Machteld [3 ]
Broekmans, Tom [1 ,3 ]
't Eijnde, Bert Op [1 ,3 ]
Feys, Peter [1 ,3 ]
机构
[1] Hasselt Univ, BIOMED Biomed Res Inst, B-3590 Diepenbeek, Belgium
[2] Hasselt Univ, SEIN Inst Social & Psychol Sci, B-3590 Diepenbeek, Belgium
[3] PHL Univ Coll, REVAL Rehabil & Hlth Care Res Ctr, Hasselt, Belgium
关键词
multiple sclerosis; habitual walking performance; ambulatory monitoring; capacity tests; self-report indices; tailored assessment; STEPWATCH ACTIVITY MONITOR; PHYSICAL-ACTIVITY; 6-MINUTE WALK; CRITERION VALIDITY; INDIVIDUALS; RELIABILITY; DISTANCE; PATIENT; IMPAIRMENT; MOBILITY;
D O I
10.1177/1352458510361357
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective was to establish the extent to which physical functioning capacity and self-report measures are able to predict the habitual walking performance in ambulatory persons with multiple sclerosis. Fifty persons with multiple sclerosis (Expanded Disability Status Scale, EDSS, 1.5-6.5) were tested on leg muscle strength as well as walking and balance capacity, and completed self-report indices on perceived physical functioning. Habitual walking performance, that is, the real amount of steps that is performed in the customary living environment, was registered by means of an ambulant accelerometer-based monitor during seven consecutive days. Mild (EDSS 1.5-4.0, n=29) and moderate (EDSS 4.5-6.5, n=21) multiple sclerosis subgroups were additionally distinguished as predictor variables and values were hypothesized to differ depending on multiple sclerosis severity and concomitant ambulatory function. Multiple regression analyses yielded a single most significant predictor for each (sub) group with other variables making no independent contribution to the variation in habitual walking performance. For the total study sample, this was the 6-Minute Walking Test (R-2=0.458, p<0.01). In the mild multiple sclerosis subgroup, the 6-Minute Walking Test was again most predictive, yet to a modest degree (R-2=0.187, p=0.02). In the moderate multiple sclerosis subgroup, the 2-Minute Walking Test explained over half of the variance (R-2=0.532, p<0.01). Habitual walking performance is best reflected by longer walking capacity tests. The extent to which it can be predicted based on clinical testing is larger in a multiple sclerosis patient sample with more severe walking disability. Ambulatory monitoring, however, includes aspects of community ambulation not captured in the clinic, and must be considered as an additional outcome for evaluating interventions in multiple sclerosis.
引用
收藏
页码:618 / 626
页数:9
相关论文
共 49 条
[1]  
Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621
[2]  
BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7
[3]  
Bethoux F., 2006, Annales de Readaptation et de Medecine Physique, V49, P355, DOI 10.1016/j.annrmp.2006.04.022
[4]   Community walking activity in neurological disorders with leg weakness [J].
Busse, ME ;
Wiles, CM ;
van Deursen, RWM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (03) :359-362
[5]   Quantified measurement of activity provides insight into motor function and recovery in neurological disease [J].
Busse, ME ;
Pearson, OR ;
Van Deursen, R ;
Wiles, CM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (06) :884-888
[6]   2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].
BUTLAND, RJA ;
PANG, J ;
GROSS, ER ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608
[7]   Criterion validity of lower extremity Motricity Index scores [J].
Cameron, D ;
Bohannon, RW .
CLINICAL REHABILITATION, 2000, 14 (02) :208-211
[8]  
Collen F M, 1991, Int Disabil Stud, V13, P50
[9]   Walking capacities in multiple sclerosis measured by global positioning system odometer [J].
Creange, A. ;
Serre, I. ;
Levasseur, M. ;
Audry, D. ;
Nineb, A. ;
Boerio, D. ;
Moreau, T. ;
Maison, P. .
MULTIPLE SCLEROSIS, 2007, 13 (02) :220-223
[10]   Development of a multiple sclerosis functional composite as a clinical trial outcome measure [J].
Cutter, GR ;
Baier, ML ;
Rudick, RA ;
Cookfair, DL ;
Fischer, JS ;
Petkau, J ;
Syndulko, K ;
Weinshenker, BG ;
Antel, JP ;
Confavreux, C ;
Ellison, GW ;
Lublin, F ;
Miller, AE ;
Rao, SM ;
Reingold, S ;
Thompson, A ;
Willoughby, E .
BRAIN, 1999, 122 :871-882